Screening for Kidney Disease in Adults With Diabetes
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Screening programs are generally aimed at conditions with a substantial public health impact and which benefit from early interventions. Chronic kidney disease (CKD), especially CKD attributed to diabetes, certainly fits this criterion. Diabetes remains the leading cause of end-stage renal disease (ESRD) in most countries in the world, accounting for 40–50% of incident ESRD cases (1–4). Due to the epidemic of diabetes secondary to obesity and the aging of the population, rates of kidney disease secondary to diabetes are on the rise. Within the past 2 decades, the incidence of ESRD secondary to diabetes in the U.S. has doubled while the prevalence of CKD among general Medicare patients diagnosed with both diabetes and hypertension has increased fourfold (1). Annual expenditures are highest for patients with ESRD secondary to diabetes compared with all other primary ESRD diagnoses (1). Thus, the epidemic of diabetes will certainly drive up health care costs for ESRD, which in the U.S. are projected to exceed $28 billion by 2010 (5). To prevent ESRD in individuals with diabetes, we must first do an adequate job of screening and detecting CKD. Unfortunately, the enormous burden of CKD remains undetected among adults with diabetes. The early detection of CKD among patients with diabetes has primarily involved the measurement of urinary albumin excretion. A timed urine collection confirmed on at least two of three occasions over a 6-month period was the initial method of screening. The acceptance of the use of the albumin (in milligrams)-to-creatinine (in grams) ratio measured in a random urine specimen has greatly expanded screening efforts due to the test’s convenience for both patients and physicians. Persistently increased levels of urine albumin excretion ≥30–299 mg/24 h or spot urine albumin-to-creatinine ratios ≥30–299 mg/g indicate the presence of microalbuminuria while urine albumin excretion levels higher than …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
Kramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618 · cited 4×
“Cross-sectional studies have found decreased GFR in the absence of increased urine albumin excretion in a substantial percentage of adults with type 2 diabetes (16).”
BackgroundInfluentialSelf-citation
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“The National Kidney Foundation classification (Table 12) is primarily based on GFR levels and may be superseded by other systems in which staging includes other variables such as urinary albumin excretion (435).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“The National Kidney Foundation classification (Table 12) is primarily based on GFR levels and therefore differs from other systems, in which staging is based primarily on urinary albumin excretion (360).”
MethodStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Metadata
- Authors
- Kramer, H., & Molitch, M. E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2005-07-01
- Volume
- 28
- Issue
- 7
- Pages
- 1813-1816
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2093935121
- Cited by
- 113
- References
- 2
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Kidney Disease in Adults With Diabetes. https://app.cochat.ai/papers/10.2337/diacare.28.7.1813
- The paper
- Kramer, H., & Molitch, M. E. (2005). Screening for Kidney Disease in Adults With Diabetes. Diabetes Care. https://doi.org/10.2337/diacare.28.7.1813
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.